Overview

Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Quetiapine Fumarate